Final Career Stage Analyses of Applications Submitted During the Pandemic (Part 7)

The HHS-declared public health emergency for COVID-19 ended on May 11, 2023 (NOT-OD-23-095). With this milestone, we are also closing out our series of blogs on the distributions of gender and race of designated principal investigators (PIs) of R01 and RPG applications submitted before and after the onset of the pandemic. This final post builds on previous career stage analyses, specifically focusing on applications received between September 8 and May 7 over several consecutive years. Our first four analyses (from April 2022, October 2021, June 2021, and July 2020) did not show any marked changes in the high-level demographics of designated principal investigators. The most recent analyses, which focused on understanding the gender distribution by career stage (reported in June 2022 and October 2022), did show that the proportion of applications designating either female or underrepresented minority early stage investigators (ESIs) increased over the assessed time periods. R01-equivalent applications received between January 8 and May 7 (Table 1) and September 8 and January 7 (Table 2) are shown according to career stage. The data include both Type 1 new applications (de novo) and Type 2 renewal applications. Please also note that these data are drawn as of May 31, 2023, and may be subject to change. Though the overall numbers received in 2022 was less than 2021, we did see a modest rebound in the number of applications in the most recent timefra...
Source: NIH Extramural Nexus - Category: Research Authors: Tags: blog Open Mike applications career stage COVID-19 Funding data Source Type: funding